These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30900520)

  • 1. Neuropathic Pain Screening: Construct Validity in Patients With Sickle Cell Disease.
    Powell-Roach K; Yao Y; Ezenwa MO; Schlaeger JM; Suarez ML; Molokie RE; Wang ZJ; Wilkie DJ
    West J Nurs Res; 2020 Feb; 42(2):125-130. PubMed ID: 30900520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A QST-based Pain Phenotype in Adults With Sickle Cell Disease: Sensitivity and Specificity of Quality Descriptors.
    Dyal BW; Ezenwa MO; Yoon SL; Fillingim RB; Yao Y; Schlaeger JM; Suarez ML; Wang ZJ; Molokie RE; Wilkie DJ
    Pain Pract; 2020 Feb; 20(2):168-178. PubMed ID: 31553824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Utility of Quantitative Sensory Testing among Adults with Sickle Cell Disease: Indicators of Neuropathic Pain?
    Ezenwa MO; Molokie RE; Wang ZJ; Yao Y; Suarez ML; Pullum C; Schlaeger JM; Fillingim RB; Wilkie DJ
    Pain Pract; 2016 Mar; 16(3):282-93. PubMed ID: 25581383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity and reliability of the Spanish-language version of the self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) pain scale.
    López-de-Uralde-Villanueva I; Gil-Martínez A; Candelas-Fernández P; de Andrés-Ares J; Beltrán-Alacreu H; La Touche R
    Neurologia (Engl Ed); 2018 Oct; 33(8):505-514. PubMed ID: 27939112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross Cultural Adaptation and Validation of Italian Version of the Leeds Assessment of Neuropathic Symptoms and Signs Scale and Pain DETECT Questionnaire for the Distinction between Nociceptive and Neuropathic Pain.
    Migliore A; Gigliucci G; Moretti A; Pietrella A; Peresson M; Atzeni F; Sarzi-Puttini P; Bazzichi L; Liguori S; Iolascon G
    Pain Res Manag; 2021; 2021():6623651. PubMed ID: 34012496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for treating neuropathic pain in people with sickle cell disease.
    Asnani MR; Francis DK; Brandow AM; Hammond Gabbadon CE; Ali A
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012943. PubMed ID: 31273755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translation, Cultural Adaptation, and Validation of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) and Self-Complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) Questionnaires into the Greek Language.
    Batistaki C; Lyrakos G; Drachtidi K; Stamatiou G; Kitsou MC; Kostopanagiotou G
    Pain Pract; 2016 Jun; 16(5):552-64. PubMed ID: 25880345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-Cultural Psychometric Assessment of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain Scale in the Portuguese Population.
    Barbosa M; Bennett MI; Verissimo R; Carvalho D
    Pain Pract; 2014 Sep; 14(7):620-4. PubMed ID: 24289475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity and reliability of the Turkish Self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire.
    Koc R; Erdemoglu AK
    Pain Med; 2010 Jul; 11(7):1107-14. PubMed ID: 20456071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity and Specificity of a Neuropathic Screening Tool (Self-Report Leeds Assessment of Neuropathic Symptoms and Signs, S-LANSS) in Adolescents With Moderate-Severe Chronic Pain.
    Walker SM; Peters J; Verriotis M; Farag F; Jay MA; Howard RF
    J Pain; 2024 Feb; 25(2):451-465. PubMed ID: 37741521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of self report version of the Leeds Assessment of Neuropathic Symptoms and Signs score for identification of neuropathic pain in patients from northern Turkey.
    Türkel Y; Türker H; Demir IA; Bayrak AO; Onar MK
    Adv Clin Exp Med; 2014; 23(4):599-603. PubMed ID: 25166445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research.
    Bennett MI; Smith BH; Torrance N; Potter J
    J Pain; 2005 Mar; 6(3):149-58. PubMed ID: 15772908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of painDETECT and S-LANSS in identifying the neuropathic component of mixed pain among patients with tumor-related cancer pain.
    Higashibata T; Tagami K; Miura T; Okizaki A; Watanabe YS; Matsumoto Y; Morita T; Kinoshita H
    Support Care Cancer; 2020 Jan; 28(1):279-285. PubMed ID: 31041583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening tools for neuropathic pain: can they be of use in individuals with spinal cord injury?
    Hallström H; Norrbrink C
    Pain; 2011 Apr; 152(4):772-779. PubMed ID: 21272997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Leeds Assessment of Neuropathic Symptoms and Signs Scale (LANSS) is not an adequate outcome measure of pressure ulcer-related neuropathic pain.
    Rutherford C; Nixon JE; Brown JM; Briggs M; Horton M
    Eur J Pain; 2016 Nov; 20(10):1710-1720. PubMed ID: 27172978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Linguistic adaptation into Spanish and psychometric validation of the ID-Pain questionnaire for the screening of neuropathic pain].
    Gálvez R; Pardo A; Cerón JM; Villasante F; Aranguren JL; Saldaña MT; Navarro A; Ruiz MA; Díaz S; Rejas J
    Med Clin (Barc); 2008 Nov; 131(15):572-8. PubMed ID: 19080838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Nepali Version of the Self-reported Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) in Adults With Chronic Pain and Predominantly Low-literacy Levels.
    Sharma S; Higgins C; Cameron P; Bimali I; Hales TG; Bennett MI; Colvin L; Smith BH
    J Pain; 2022 Mar; 23(3):424-433. PubMed ID: 34583020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-cultural Adaptation and Linguistic Validation of the Korean Version of the Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale.
    Park C; Lee YW; Yoon DM; Kim DW; Nam DJ; Kim DH
    J Korean Med Sci; 2015 Sep; 30(9):1334-9. PubMed ID: 26339176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) questionnaire and its correlation with visual analog pain scales in Greek population.
    Spanos K; Lachanas VA; Chan P; Bargiota A; Giannoukas AD
    J Diabetes Complications; 2015; 29(8):1142-5. PubMed ID: 26345340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-Reported Neuropathic Pain Characteristics of Women With Provoked Vulvar Pain: A Preliminary Investigation.
    Dargie E; Gilron I; Pukall CF
    J Sex Med; 2017 Apr; 14(4):577-591. PubMed ID: 28325536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.